LGC lists over 2,600 impurity reference standards in its new pharmaceutical reference substances and impurities catalogue, which has been compiled to help drug firms meet FDA guidelines.
The LGC range of impurities for important active pharmaceutical ingredients (APIs) has expanded at a rate of more than two new standards per week since the last catalogue was issued in 2009.
In addition to impurities, the catalogue includes up-to-date listings from all the major pharmacopoeia worldwide, making it an ideal resource for anyone involved in pharmaceutical quality control.
The catalogue also contains a new product line of nearly 100 secondary pharmaceutical standards traceable to the US, European and British pharmacopoeias.
These products are supplied with a certificate of analysis that documents the traceability.
The catalogue contains details of the World Health Organisation reference materials for use with the International Pharmacopoeia, which were unavailable until recently.
